Leonteq Securities AG’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$882 Hold
43
﹤0.01% 1184
2026
Q1
$684 Hold
43
﹤0.01% 1212
2025
Q4
$1.13K Hold
43
﹤0.01% 1338
2025
Q3
$972 Hold
43
﹤0.01% 1251
2025
Q2
$855 Hold
43
﹤0.01% 1205
2025
Q1
$726 Hold
43
﹤0.01% 1175
2024
Q4
$794 Hold
43
﹤0.01% 1194
2024
Q3
$934 Hold
43
﹤0.01% 1125
2024
Q2
$844 Hold
43
﹤0.01% 1136
2024
Q1
$933 Hold
43
﹤0.01% 1157
2023
Q4
$1.24K Hold
43
﹤0.01% 1140
2023
Q3
$1.15K Hold
43
﹤0.01% 1146
2023
Q2
$1.59K Hold
43
﹤0.01% 1164
2023
Q1
$1.34K Hold
43
﹤0.01% 1157
2022
Q4
$1.28K Hold
43
﹤0.01% 1212
2022
Q3
$1.64K Sell
43
-303
-88% -$15.2K ﹤0.01% 1196
2022
Q2
$18.9K Buy
346
+53
+18% +$2.91K ﹤0.01% 984
2022
Q1
$18.3K Sell
293
-24
-8% -$1.58K ﹤0.01% 1016
2021
Q4
$31.9K Sell
317
-2,500
-89% -$220K ﹤0.01% 979
2021
Q3
$253K Sell
2,817
-1,683
-37% -$153K 0.01% 537
2021
Q2
$415K Sell
4,500
-3,000
-40% -$240K 0.02% 423
2021
Q1
$725K Buy
7,500
+1,250
+20% +$129K 0.04% 323
2020
Q4
$326K Buy
+6,250
New +$261K 0.02% 488

Other funds holding FLGT

Leonteq Securities AG's FLGT Position: Q2 2026 in Review

Leonteq Securities AG held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 43 shares worth $882. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

Leonteq Securities AG first reported a position in FLGT in Q4 2020 and has held it in 23 quarters since. The position peaked at $725K in Q1 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Leonteq Securities AG held 43 shares of Fulgent Genetics worth $882 as of Q2 2026.
  • Leonteq Securities AG left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1184 holding.
  • Leonteq Securities AG first reported a position in Fulgent Genetics in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Fulgent Genetics position peaked at $725K in Q1 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.